H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 16.32 HKD 2%
Updated: May 31, 2024
Section:
 

Relative Value

The Relative Value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 16.32 HKD, Hansoh Pharmaceutical Group Company Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Hansoh Pharmaceutical Group Company Ltd Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

8.9
P/S
P/S
Price to Sales
8.9
vs History
42
vs Industry
17
Median 3Y
8
Median 5Y
8.4
Industry
2.4
Forward
7.2
More Details
27.3
P/E
P/E
Price to Earnings
27.3
vs History
63
vs Industry
18
Median 3Y
28.7
Median 5Y
29.3
Industry
22.8
Forward
23.3
More Details
28.7
P/OCF
P/OCF
Price to OCF
28.7
vs History
54
vs Industry
16
Median 3Y
28.4
Median 5Y
30.6
Industry
17
More Details
31.1
P/FCFE
P/FCFE
Price to FCFE
31.1
vs History
45
vs Industry
17
Median 3Y
29.1
Median 5Y
29.7
Industry
23.2
More Details
3.5
P/B
P/B
Price to Book Value
3.5
vs History
65
vs Industry
23
Median 3Y
3.6
Median 5Y
4
Industry
2.1
More Details
6.2
EV/S
EV/S
Enterprise Value to Sales
6.2
vs History
49
vs Industry
21
Median 3Y
6.2
Median 5Y
6.4
Industry
2.6
Forward
5.2
More Details
6.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.9
vs History
45
vs Industry
31
Median 3Y
6.8
Median 5Y
7.1
Industry
5.1
More Details
20.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
20.9
vs History
42
vs Industry
17
Median 3Y
19.9
Median 5Y
20.5
Industry
13.5
Forward
14.9
More Details
23.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.8
vs History
42
vs Industry
19
Median 3Y
22.4
Median 5Y
23.1
Industry
16.9
Forward
16.3
More Details
20.2
EV/OCF
EV/OCF
Enterprise Value to OCF
20.2
vs History
59
vs Industry
22
Median 3Y
21.4
Median 5Y
22.7
Industry
15.8
More Details
21.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
21.7
vs History
63
vs Industry
19
Median 3Y
23.6
Median 5Y
25
Industry
17.7
More Details
7.8
EV/IC
EV/IC
Enterprise Value to IC
7.8
vs History
59
vs Industry
12
Median 3Y
7.7
Median 5Y
8.8
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
Hansoh Pharmaceutical Group Company Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
94.8B HKD 8.9 27.3 20.9 23.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
773.6B USD 21.5 126 61.6 70.1
DK
Novo Nordisk A/S
CSE:NOVO B
4.1T DKK 16.7 45.8 34.1 37.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
349.6B USD 4.1 9.1 11.2 14.6
US
Merck & Co Inc
NYSE:MRK
315.5B USD 5.1 136.8 34.2 55.8
UK
AstraZeneca PLC
LSE:AZN
186.5B GBP 5 37.4 174.5 278.3
CH
Roche Holding AG
SIX:ROG
182B CHF 3.1 15.8 9 10.7
CH
Novartis AG
SIX:NOVN
178.4B CHF 3.4 11.3 8.6 12.5
US
Pfizer Inc
NYSE:PFE
159.8B USD 2.9 -517.2 12.6 20.3
P/E Multiple
Earnings Growth
CN
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Average P/E: 51.2
27.3
31%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
126
364%
DK
Novo Nordisk A/S
CSE:NOVO B
45.8
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.1
-21%
US
Merck & Co Inc
NYSE:MRK
136.8
7 598%
UK
AstraZeneca PLC
LSE:AZN
37.4
175%
CH
Roche Holding AG
SIX:ROG
15.8
28%
CH
Novartis AG
SIX:NOVN
11.3
17%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -517.2
683%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 142,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.